Kymera Therapeutics, Inc. (KYMR)

78.14 -2.21 (-2.75%) USD  |  NASDAQ  |  Dec 30, 12:48
More

Kymera Therapeutics EPS Basic from Accounting Change (Quarterly)

EPS Basic from Accounting Change (Quarterly) Chart

View EPS Basic from Accounting Change (Quarterly) for KYMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Basic from Accounting Change (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Basic from Accounting Change (Quarterly) Range, Past 5 Years

View EPS Basic from Accounting Change (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Basic from Accounting Change (Quarterly) Benchmarks

View EPS Basic from Accounting Change (Quarterly) Benchmarks
Start Trial
Gilead Sciences, Inc. --
Regeneron Pharmaceuticals, Inc. --
Cytokinetics, Inc. --
TG Therapeutics, Inc. --
Protagonist Therapeutics, Inc. --